Early transcriptomic changes predict long-term treatment outcome of ketamine versus midazolam in patients with treatment-resistant depression in the KADS study

Neuroscience Applied 2026 Open access

Read full text
Authors: S.M. Wissing, C. Hohoff, E. Van Assche, T. Lange, L. Steinbach, D. Barton, M. Berk, G.L. Carter, V. Dong, P.B. Fitzgerald, V. Galvez, N. Glozier
+13 more Paul Glue, M.L. Hackett, D. Hadzi-Pavlovic, A.J. Harvey, S. Hood, D.M. Martin, P.B. Mitchell, N. Mills, S. Sarma, Andrew Alexander Somogyi, A. Rodgers, CK Loo, B.T. Baune
DOI: 10.1016/j.nsa.2025.105591
Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Tryptophan and brain disorders Memory and Neural Mechanisms

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
105591–105591
Publication date
1 January 2026
Language
EN